Overactive Bladder - Results from #1120

[Tolerability, persistence and satisfaction. Retrospective cohort study in patients with overactive bladder syndrome treated with transdermal Oxybutynin under Standard ClinicAl pRactice. OSCAR Study.] July 9, 2017

Comparative Assessment of Efficacy of OnabotulinumtoxinA and Oral Therapies (Anticholinergics and Mirabegron) for Overactive Bladder: A Systematic Review and Network Meta-analysis July 9, 2017

Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation July 9, 2017

Trends and Clinical Practice Patterns of Sacral Neuromodulation for Overactive Bladder July 2, 2017

One and the Same? Nocturnal Enuresis and Overactive Bladder in the Female Veteran Population: Evaluation of a Large National Database July 2, 2017

Where Are We Headed with Neuromodulation for Overactive Bladder? July 2, 2017

Older People's Preferences for Side Effects Associated with Antimuscarinic Treatments of Overactive Bladder: A Discrete-Choice Experiment July 2, 2017

Longitudinal Associations between Mental Health Conditions and Overactive Bladder in Women Veterans June 25, 2017

Real-Time Changes in Brain Activity During Sacral Neuromodulation for Overactive Bladder June 25, 2017

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial June 25, 2017

Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management June 25, 2017

Association between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women with Overactive Bladder June 23, 2017

Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction? June 18, 2017

A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study) June 18, 2017

Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives June 18, 2017

Overactive Bladder Symptom Scores responsiveness before and after anticholinergic treatment in women with overactive bladder: The pilot study June 18, 2017

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies June 10, 2017

[Food, diet and dietetic in treatment of urinary tract dysfunctions. A review] June 9, 2017

MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin-A injection June 9, 2017

Stimulus-associated urinary urges in overactive bladder syndrome. May 27, 2017

Page 57 of 122